|
Functional determinants of metastatic dormancy
|
7R01CA109182-05
|
$303,516
|
$75,879
|
AGUIRRE-GHISO, JULIO
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Design of Antiviral Drugs Effective Against the HIV-1 Virus
|
Z01 BC 009101
|
$135,938
|
$40,781
|
Appella, Ettore
|
CCR (NCI)
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
Z01 BC 010997
|
$178,059
|
$89,030
|
Avital, Itzhak
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
Z01 BC 011004
|
$89,029
|
$8,903
|
Avital, Itzhak
|
CCR (NCI)
|
|
Mid-Region AIDS and Cancer Specimen Resource Consortium
|
3U01CA066531-13S1
|
$274,911
|
$208,423
|
AYERS, LEONA
|
OHIO STATE UNIVERSITY
|
|
Hsp90 as a Target for the Treatment of Childhood Cancer
|
5K23CA107450-03
|
$119,402
|
$119,402
|
BAGATELL, ROCHELLE
|
UNIVERSITY OF ARIZONA
|
|
Chemically Programmed Antibodies for Cancer Therapy
|
5R01CA104045-05
|
$294,676
|
$58,935
|
BARBAS, CARLOS
|
SCRIPPS RESEARCH INSTITUTE
|
|
COG studies of gene amplification in rhabdomyosarcoma
|
5R01CA104896-04
|
$417,146
|
$417,146
|
BARR, FREDERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Pain: Nerve/Tumor Interactions
|
5R01CA084233-07
|
$335,452
|
$167,726
|
BEITZ, ALVIN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Prolactin as a Growth Factor in Breast Cancer
|
5R01CA096613-05
|
$238,696
|
$35,804
|
BEN-JONATHAN, NIRA
|
UNIVERSITY OF CINCINNATI
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$119,597
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
Z01 SC 004020
|
$1,350,223
|
$135,022
|
Berzofsky, Jay
|
CCR (NCI)
|
|
A Mouse Model for Human Gastrointestinal Stromal Tumor
|
5R01CA102774-05
|
$354,934
|
$354,934
|
BESMER, PETER
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Genetics of pediatric rhabdoid tumors
|
2R01CA046274-17A2
|
$266,860
|
$88,064
|
BIEGEL, JACLYN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
The Molecular Analysis of Tumor Viruses
|
5T32CA009043-34
|
$624,449
|
$124,890
|
BISHOP, J
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
HIV Tat Transcriptional Activation
|
Z01 BC 005753
|
$291,643
|
$58,329
|
Brady, John
|
CCR (NCI)
|
|
Extending and Interpreting Molecular Portraits of Cancer
|
5R01CA111487-03
|
$231,418
|
$78,682
|
BROWN, PATRICK
|
STANFORD UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA046934-21S3
|
$85,992
|
$44,922
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
Z01 BC 007363
|
$261,903
|
$222,618
|
Burke, Terrence
|
CCR (NCI)
|
|
Effects of Photodynamic Therapy on Tumor Oxygenation and Blood Flow
|
2R01CA085831-06A2
|
$308,431
|
$61,686
|
Busch, Theresa
|
UNIVERSITY OF PENNSYLVANIA
|
|
Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway
|
Z01 BC 011131
|
$198,798
|
$119,279
|
Byrd, R. Andrew
|
CCR (NCI)
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-33S1
|
$89,606
|
$38,433
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
Z01 BC 010791
|
$737,332
|
$73,733
|
Carrington, Mary
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA016087-28
|
$2,640,338
|
$26,403
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Randomized Phase II Study of QS-DG +/- Trivalent Ganglioside Vaccine in Stage IV
|
1R21CA133866-01A1
|
$426,881
|
$286,010
|
Carvajal, Richard
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
KSHV vFLIP in B cell survival
|
5R01CA103646-05
|
$326,554
|
$326,554
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
Antigens of Kaposi's sarcoma associated herpesvirus
|
2R01CA075911-12A1
|
$310,171
|
$310,171
|
Chandran, Bala
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
Role of orf-K13, an HHV8 Encoded vFLIP, in the Pathogenesis of AIDS-related Malig
|
5R01CA085177-09
|
$236,554
|
$236,554
|
Chaudhary, Preet
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Biochemical Aspects of Chemotherapy
|
5T32CA009085-34
|
$310,322
|
$77,581
|
CHENG, YUNG-CHI
|
YALE UNIVERSITY
|
|
Sleeping Beauty for cancer gene discovery
|
7K01CA122183-03
|
$166,185
|
$109,682
|
Collier, Lara
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Plasmacytoid Dendritic Cells in Anti-Tumor Response
|
5R01CA109673-04
|
$227,715
|
$170,786
|
COLONNA, MARCO
|
WASHINGTON UNIVERSITY
|
|
Immune evasion by KSHV
|
5R01CA108447-05
|
$232,411
|
$232,411
|
COSCOY, LAURENT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S1
|
$80,987
|
$49,046
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Oncolytic HSV Therapy in Immunocompetent Sarcoma Models
|
5R01CA114004-03
|
$258,529
|
$258,529
|
CRIPE, TIMOTHY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
1P30CA134274-01
|
$1,463,613
|
$43,908
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Viral Oncology Training Grant
|
2T32CA009111-31A2
|
$318,261
|
$31,826
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Role of KSHV K1 in viral pathogenesis
|
5R01CA096500-07
|
$279,757
|
$279,757
|
DAMANIA, BLOSSOM
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant - P30
|
3P30CA093373-07S2
|
$119,309
|
$62,533
|
de Vere White, Ralph
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
PROTON RADIATION THERAPY RESEARCH
|
2P01CA021239-29A1
|
$1,692,753
|
$101,565
|
DELANEY, THOMAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
NMR detection of tumor differentiation
|
5R01CA114347-04
|
$237,454
|
$59,364
|
DELIKATNY, EDWARD
|
UNIVERSITY OF PENNSYLVANIA
|
|
Molecular Mechanisms in Gastrointestinal Stromal Tumor
|
5R01CA102613-05
|
$573,359
|
$573,359
|
DEMATTEO, RONALD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Biological activity of ras oncogenes
|
5R01CA042978-22
|
$319,853
|
$63,971
|
DER, CHANNING
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Hyperthermia and Perfusion Effects in Cancer Therapy
|
5P01CA042745-22
|
$2,867,786
|
$716,947
|
DEWHIRST, MARK
|
DUKE UNIVERSITY
|
|
Molecular Basis of Viral and Cellular Transformation
|
3P01CA016038-35S1
|
$91,548
|
$156,651
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
Regulation of the KSHV latent promoter
|
5R01CA109232-05
|
$225,602
|
$225,602
|
DITTMER, DIRK
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
OHSU Cancer Institute
|
3P30CA069533-12S1
|
$69,612
|
$133,618
|
DRUKER, BRIAN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Role of MAPK signaling in Kaposi's sarcoma-associated herpersvirus pathogenesis
|
1F31CA132560-01A1
|
$27,772
|
$27,772
|
Dyson, Ossie
|
EAST CAROLINA UNIVERSITY
|
|
Cancer Center Core Support Grant
|
3P30CA016086-33S2
|
$249,275
|
$135,925
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
PET in Sarcoma - A Clinical Trial
|
5R01CA065537-13
|
$26,940
|
$13,470
|
Eary, Janet
|
UNIVERSITY OF WASHINGTON
|
|
Cancer Center Support Grant
|
3P30CA091842-08S1
|
$87,870
|
$82,117
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
Total relevant funding to Sarcoma, Soft (Sarcoma Subset) for this search: $50,451,328
|